Browsing Tag

Amydis

Amydis Awarded Third Grant From The Michael J. Fox Foundation To Support…

Eli Pacheco Oct 27, 2022 0

SAN DIEGO, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Amydis Inc., a privately held clinical-stage company pioneering a platform of diagnostic drug candidates targeting molecular biomarkers in the…

Health

Amydis Receives NIH Grant Award to Develop a Novel TDP-43 Retinal Tracer in Patients…

Eli Pacheco Aug 18, 2022 0

SAN DIEGO, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer pharmaceutical company with a broad portfolio of diagnostic drug candidates targeting CNS biomarkers in…

Health

Amydis Awarded $3 Million NIH Grant to Explore Novel Alpha Synuclein Retinal Tracer…

Eli Pacheco Oct 11, 2021 0

SAN DIEGO, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer pharmaceutical company with a broad portfolio of diagnostic drug candidates targeting CNS biomarkers in…

Health

Amydis Receives NIH Grant Award to Develop a Novel Tau Retinal Tracer for…

Eli Pacheco Sep 2, 2021 0

SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer pharmaceutical company with a broad portfolio of diagnostic drug candidates targeting CNS biomarkers in…